Your browser doesn't support javascript.
loading
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.
Kester, Maartje I; Teunissen, Charlotte E; Crimmins, Daniel L; Herries, Elizabeth M; Ladenson, Jack H; Scheltens, Philip; van der Flier, Wiesje M; Morris, John C; Holtzman, David M; Fagan, Anne M.
Afiliação
  • Kester MI; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.
  • Teunissen CE; Department of Clinical Chemistry, VU University Medical Center, Amsterdam, the Netherlands.
  • Crimmins DL; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
  • Herries EM; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
  • Ladenson JH; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
  • Scheltens P; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.
  • van der Flier WM; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands4Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.
  • Morris JC; The Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri6Department of Neurology, Washington University School of Medicine, St Louis, Missouri7Hope Center for Neurological Disorders, Washington Universit.
  • Holtzman DM; The Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri6Department of Neurology, Washington University School of Medicine, St Louis, Missouri7Hope Center for Neurological Disorders, Washington Universit.
  • Fagan AM; The Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, Missouri6Department of Neurology, Washington University School of Medicine, St Louis, Missouri7Hope Center for Neurological Disorders, Washington Universit.
JAMA Neurol ; 72(11): 1275-80, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26366630
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sinapses / Progressão da Doença / Neurogranina / Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sinapses / Progressão da Doença / Neurogranina / Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article